Week in Review: China Investors Announce $4 Billion of Life Science Deals

Knowledgeable observers expect the IPO to take place in Q2, raise $300 million and value WuXi Biologics at $1.5 billion. Sanpower Group enlisted China’s CITIC Bank, a state-owned investor, to raise $2.9 billion for a healthcare M&A fund, which will fund …
( read original story …)